Sector
Congress Trading Healthcare Stocks
Healthcare is one of the most legislatively sensitive sectors for congressional trading. Members who sit on the Senate HELP Committee, the House Energy & Commerce Committee, and their health subcommittees oversee drug pricing, Medicare negotiation, FDA funding, and insurance regulation. Those same members hold and trade pharmaceutical, biotech, and insurance stocks disclosed under the STOCK Act.
0
Total disclosures
0
Members trading
0%
% purchases
Recent healthcare disclosures
No trades on record for this sector yet.
Frequently asked questions
Which healthcare stocks do members of Congress trade most?
Large-cap pharmaceutical companies including Johnson & Johnson, Pfizer, AbbVie, and Merck appear frequently in filings. Health insurers like UnitedHealth Group and CVS Health also show up regularly. Biotech positions are less common due to their volatility.
Is there a conflict of interest with Congress trading pharma stocks?
The conflict-of-interest concern is significant. Members who vote on drug pricing legislation, Medicare drug negotiation provisions, and FDA appropriations also hold positions in the companies directly affected by those votes. The STOCK Act requires disclosure but does not require divestiture.
Did members of Congress trade healthcare stocks around the Inflation Reduction Act drug pricing provisions?
The Inflation Reduction Act (2022) included provisions allowing Medicare to negotiate drug prices for the first time. Trading patterns in pharmaceutical stocks around that legislation attracted scrutiny. Establishing a causal link between legislative knowledge and specific trades requires evidence of material non-public information, which has not been established in public investigations.
How often do healthcare sector disclosures appear?
Healthcare trades are disclosed year-round. Capitol Trader updates daily from STOCK Act filings, so new healthcare sector disclosures appear as soon as members file them with the House or Senate clerk.